Genetic determinants of immune-response to a polysaccharide vaccine for typhoid (original) (raw)

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a

Stephen Lockhart

PLOS Neglected Tropical Diseases, 2016

View PDFchevron_right

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases

Huan Nguyen

Emerging Infectious Diseases, 2000

View PDFchevron_right

Mucosal immunity and HIV/AIDS vaccines

Marc GIRARD

Vaccine, 2008

View PDFchevron_right

A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India

Shanta Dutta

New England Journal of Medicine, 2009

View PDFchevron_right

Preclinical evaluation: Toxicity of Single Dose of the vaccine Typhoid of Polysaccharide Vi Conjugate in Sprague Dawley rats

Reynaldo Oliva

2015

View PDFchevron_right

Influence of cytokine gene variations on immunization to childhood vaccines

James Slaven

Vaccine, 2009

View PDFchevron_right

Typhoid fever infection – Antibiotic resistance and vaccination strategies: A narrative review

Jorge Atouguia

Travel Medicine and Infectious Disease, 2021

View PDFchevron_right

Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies

laura rodrigues

International Journal of Epidemiology, 1984

View PDFchevron_right

Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform

Sri Hadinegoro

Public Health, 2006

View PDFchevron_right

Mucosal vaccines — fortifying the frontiers

evelyn palomino

Nature Reviews Immunology, 2021

View PDFchevron_right

Human Leukocyte Antigen Haplotypes in the Genetic Control of Immune Response to Measles‐Mumps‐Rubella Vaccine

Shane Pankratz

The Journal of Infectious Diseases, 2006

View PDFchevron_right

Mucosal Vaccines: An Overview

Cecil Czerkinsky

Elsevier eBooks, 2005

View PDFchevron_right

“Oral Vaccine Antigen Induced Immune Response Signalling Pathways: Current and Future Perspectives”

Anoop kumar

Journal of Vaccines & Vaccination, 2014

View PDFchevron_right

Effectiveness of Typhoid Conjugate Vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study

Farayi Marume

2022

View PDFchevron_right

Allergies to vaccines in children

Darko Richter

The Central European Journal of Paediatrics, 2017

View PDFchevron_right

Challenges of Developing Novel Vaccines With Particular Global Health Importance

Penny Heaton

Frontiers in Immunology, 2020

View PDFchevron_right

Therapeutic vaccines

James Gulley

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Vaccine development: From concept to early clinical testing

Nathalie Garcon

Vaccine, 2016

View PDFchevron_right

A TLR4 ligand-based adjuvant for promoting the immunogenicity of Typhoid subunit vaccines

Kishore Alugupalli

bioRxiv (Cold Spring Harbor Laboratory), 2024

View PDFchevron_right

Vaccination: A homoeopathic viewpoint

Nishi Agarwal

International Journal of Homoeopathic Sciences

View PDFchevron_right

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

Steven Wassilak

New England Journal of Medicine, 1996

View PDFchevron_right

A parenteral DNA vaccine protects against pneumonic plague

Xinghong Yang

Vaccine, 2010

View PDFchevron_right

How to determine protective immunity in the post-vaccine era

Carmen Charlton

Human Vaccines & Immunotherapeutics, 2016

View PDFchevron_right

Human Leukocyte Antigen Genotypes in the Genetic Control of Adaptive Immune Responses to Smallpox Vaccine

Robert Jacobson, Inna G Ovsyannikova

Journal of Infectious Diseases, 2011

View PDFchevron_right

Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development

Inna G Ovsyannikova

The AAPS Journal, 2011

View PDFchevron_right

A step backwards in the fight against global vaccine inequities

Eivind Engebretsen

The Lancet, 2021

View PDFchevron_right

Assessing the Feasibility of Typhoid Elimination

Phionah Atuhebwe

Clinical Infectious Diseases, 2020

View PDFchevron_right

Regulatory T-cell vaccination independent of auto-antigen

Xinghong Yang

Experimental & Molecular Medicine, 2014

View PDFchevron_right

4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (Adjuvant 2008)

Oliver Perez

Expert Review of Vaccines, 2008

View PDFchevron_right

Dose‐Dependent Neutralizing‐Antibody Responses to Vaccinia

ROBERT BELSHE

The Journal of Infectious Diseases, 2004

View PDFchevron_right

Head-to-Head Comparison of Humoral Immune Responses to Vi Capsular Polysaccharide and Salmonella Typhi Ty21a Typhoid Vaccines–A Randomized Trial

Anu Kantele

PLoS ONE, 2013

View PDFchevron_right

Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae

Anu Kantele

Vaccine, 2014

View PDFchevron_right

Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines

Fernanda Tavares

Vaccine, 2013

View PDFchevron_right

Immunogenecity of Hepatitis A and B Vaccination in Pediatric Patients With Inflammatory Bowel Disease

Derya Kalyoncu

Journal of Pediatric Gastroenterology and Nutrition, 2013

View PDFchevron_right

Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines

Diana Boraschi

Infection and Immunity, 1988

View PDFchevron_right